Purchase Order 75N92022P00225
Award Date 8/1/22
Potential Completion Date 12/31/22
Potential Value $118K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the supply and installation of a Sequel II DNA sequencing machine by Pacific Biosciences of California, Inc., a manufacturer of specialized scientific equipment. The contract, valued at $522,500.00, was awarded on May 13, 2019 by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations. The contract is a firm-fixed price purchase order with a completion date of June 9, 2019. Pacific...
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $63,600 firm fixed price purchase order to Pacific Biosciences of California, Inc. for COMP. SEQUEL II SRV CONTRACT W/O INSIGHT. As the award references sequencing services without insight, it can be inferred the contract is to provide next generation DNA sequencing capabilities to support NIH research initiatives. Pacific Biosciences will perform the sequencing work...
- This $274,176 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Pacific Biosciences of California, Inc., a for-profit manufacturer. The contract is for the delivery of PacBio Revio sequencing reagents, which support the agency's genomic research initiatives. Pacific Biosciences is the original equipment manufacturer for the proprietary PacBio Sequel and Sequel II DNA/RNA sequencing...
- This contract award to Pacific Biosciences of California, Inc. is for the provision of a PacBio Sequel System 8M Upgrade. The contract, valued at $220,000.00, was awarded on a firm fixed price basis by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute. The contract does not have a set-aside designation. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services associated with their Sequel...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Pacific Biosciences of California, Inc. on July 19, 2018 for the provision of a PacBio Sequel DNA sequencer. The potential value of the contract is $337,500.00. Pacific Biosciences is a manufacturer and provider of specialized scientific equipment, reagents, and services associated with their Sequel and Sequel II DNA/RNA...
- This federal contract award is to Pacific Biosciences of California, Inc., a small business manufacturer of high-throughput, long-read DNA sequencing systems and associated consumables. The $22,845.96 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health, for the delivery of their Sequel and Sequel II sequencing platforms and related products. Pacific Biosciences holds two significant Indefinite...
- This firm-fixed-price purchase order for $32,500.00 was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Pacific Biosciences of California, Inc. to provide their Sequel and Sequel II DNA/RNA sequencing systems, reagent kits, consumables, and preventative maintenance services. This contract is not designated as a set-aside. Pacific Biosciences is a manufacturer of specialized scientific equipment and a major provider of sequencing...
- Pacific Biosciences of California, Inc. was awarded a $53,000 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to provide a Sequel II instrument service contract with insight from August 15, 2023 through August 14, 2024. The contract will deliver service and support for Pacific Biosciences' Sequel II sequencing systems to assist the agency's genomic research efforts. No set aside designation or subcontractors were identified. The...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $63,802 purchase order to Pacific Biosciences of California, Inc. for SMRT cell and sequence reagents to operate the Sequel II sequencing platform. As a prime contractor, Pacific Biosciences will deliver the requested products to support genomic sequencing efforts at their West Menlo Park, California location of performance. The firm-fixed price contract runs from August...
- This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Pacific Biosciences of California, Inc. for the delivery of REVIO SPRQ REAGENT KIT. The contract has a ceiling value of $137,088.00 and a period of performance through February 28, 2025. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by various federal agencies to...